Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a post hoc analysis of ORAL Surveillance

BACKGROUND: In patients with rheumatoid arthritis (RA), persistent inflammation and increasing disease activity are associated with increased risk of adverse events (AEs). OBJECTIVES: To assess relationships between RA disease activity and AEs of interest in patients treated with tofacitinib or tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Karpouzas, George A., Szekanecz, Zoltán, Baecklund, Eva, Mikuls, Ted R., Bhatt, Deepak L., Wang, Cunshan, Sawyerr, Gosford A., Chen, Yan, Menon, Sujatha, Connell, Carol A., Ytterberg, Steven R., Mortezavi, Mahta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629315/
https://www.ncbi.nlm.nih.gov/pubmed/37942277
http://dx.doi.org/10.1177/1759720X231201047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629315/
https://www.ncbi.nlm.nih.gov/pubmed/37942277
http://dx.doi.org/10.1177/1759720X231201047

Ejemplares similares